Poellabauer EM - Search Results

1

A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory.

Loew-Baselli A, Pavlova BG, Fritsch S, Poellabauer EM, Draxler W, Kistner O, Behre U, Angermayr R, Neugebauer J, Kirsten K, Förster-Waldl E, Koellges R, Ehrlich HJ, Barrett PN. Loew-Baselli A, et al. Among authors: poellabauer em. Vaccine. 2012 Sep 7;30(41):5956-66. doi: 10.1016/j.vaccine.2012.07.039. Epub 2012 Jul 28. Vaccine. 2012. PMID: 22846396 Clinical Trial.

2

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.

Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Koska M, Bobrovsky R, Konior R, Ehrlich HJ. Loew-Baselli A, et al. Among authors: poellabauer em. Hum Vaccin. 2009 Aug;5(8):551-6. doi: 10.4161/hv.5.8.8571. Hum Vaccin. 2009. PMID: 19430202

3

Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants.

Poellabauer EM, Pavlova BG, Fritsch S, Singer J, Neubauer C, Doralt J, Valenta-Singer B, Ehrlich HJ. Poellabauer EM, et al. Vaccine. 2013 Aug 2;31(35):3611-6. doi: 10.1016/j.vaccine.2013.04.070. Epub 2013 May 11. Vaccine. 2013. PMID: 23672977 Free article. Clinical Trial.

4

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

Loew-Baselli A, Konior R, Pavlova BG, Fritsch S, Poellabauer E, Maritsch F, Harmacek P, Krammer M, Barrett PN, Ehrlich HJ; FSME-IMMUN study group. Loew-Baselli A, et al. Vaccine. 2006 Jun 12;24(24):5256-63. doi: 10.1016/j.vaccine.2006.03.061. Epub 2006 Apr 3. Vaccine. 2006. PMID: 16624457 Clinical Trial.

5

Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.

Poellabauer E, Angermayr R, Behre U, Zhang P, Harper L, Schmitt HJ, Erber W. Poellabauer E, et al. Vaccine. 2019 May 27;37(24):3241-3250. doi: 10.1016/j.vaccine.2019.03.032. Epub 2019 Mar 27. Vaccine. 2019. PMID: 30928173 Clinical Trial.

6

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance.

Pavlova BG, Loew-Baselli A, Fritsch S, Poellabauer EM, Vartian N, Rinke I, Ehrlich HJ. Pavlova BG, et al. Among authors: poellabauer em. Vaccine. 2003 Jan 30;21(7-8):742-5. doi: 10.1016/s0264-410x(02)00593-5. Vaccine. 2003. PMID: 12531353

7

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.

Ehrlich HJ, Pavlova BG, Fritsch S, Poellabauer EM, Loew-Baselli A, Obermann-Slupetzky O, Maritsch F, Cil I, Dorner F, Barrett PN. Ehrlich HJ, et al. Among authors: poellabauer em. Vaccine. 2003 Dec 12;22(2):217-23. doi: 10.1016/s0264-410x(03)00563-2. Vaccine. 2003. PMID: 14615149 Clinical Trial.

8

Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.

Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Firth C, Petermann R, Barrett PN, Ehrlich HJ. Loew-Baselli A, et al. Among authors: poellabauer em. Vaccine. 2011 Oct 6;29(43):7307-19. doi: 10.1016/j.vaccine.2011.07.089. Epub 2011 Aug 16. Vaccine. 2011. PMID: 21843576 Review.

9

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.

Orlinger KK, Hofmeister Y, Fritz R, Holzer GW, Falkner FG, Unger B, Loew-Baselli A, Poellabauer EM, Ehrlich HJ, Barrett PN, Kreil TR. Orlinger KK, et al. Among authors: poellabauer em. J Infect Dis. 2011 Jun 1;203(11):1556-64. doi: 10.1093/infdis/jir122. J Infect Dis. 2011. PMID: 21592984 Clinical Trial.

10

Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.

Konior R, Brzostek J, Poellabauer EM, Jiang Q, Harper L, Erber W. Konior R, et al. Among authors: poellabauer em. Vaccine. 2017 Jun 16;35(28):3607-3613. doi: 10.1016/j.vaccine.2017.03.059. Epub 2017 May 22. Vaccine. 2017. PMID: 28545923 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters